Pharmaceutical Services - Resources and Insights
Our library of digital resources is available to enhance your knowledge-base and educate you along every step of the drug development process. Keep up-to-date with industry hot topics and the latest research developed by our thought-leaders.
- ARTICLE: Repurposing Vaccines for Intranasal Development
- E-BOOK: Flexible Contingency Outsourcing Solutions
- FACTSHEET: COVID-19 Vaccine and Therapeutic Testing and Development Outsourcing Solutions
- WEBINAR: Quality Control Strategy for Vaccine Development - Rapid Response Strategies
- WEBINAR: Repurposing Products for Inhaled Delivery - Rapid Response Strategies
- ARTICLE: Good Practice for Pharmaceutical Remote Audits
- ARTICLE: Mitigating Risks in Pharmaceutical Batch Release - Enabling contingency sourcing for analytical supplies
- WHITE PAPER: Biophysical Characterisation of Tocilizumab
- BROCHURE: Biopharmaceutical Services
- BROCHURE: Pharmaceutical Services
- WHITE PAPER: Biophysical Characterisation of Tocilizumab
- WHITE PAPER: Monitoring of Glycosylation Analytical Approaches for Antibody-Based Therapeutics
- Article: Intranasal Delivery of Biologic Therapeutics and Vaccines
- ARTICLE: Biosimilar Characterisation and Immunogenicity
- ARTICLE: Characterization of Bispecifics
- ARTICLE: Monoclonal Antibody Structural Characterization Challenges
- ARTICLE: New Approaches to Bioassay Design
- ARTICLE: Physicochemical Properties of Liposomal Advanced Drug Delivery Technologies
- PUBLICATION: Pharma's Almanac Expert Discussion: Technology Developments Impacting Industry
- REPORT: Current Analytical Approaches to Biophysical Characterisation in a Regulatory Environment
- REPORT: Designing a Strategic Science-Led Quality Control Program for Peptide Therapeutics
- WEBINAR: Evolution of a Cell-based Assay
- WEBINAR: Monitoring Glycosylation Using Site Specific Approaches
- WEBINAR: Strategic Development of Characterisation and Quality Control Programs for Therapeutic Peptides
- WHITEPAPER: GMP Flow Cytometry - Applications,Considerations and Challenges
- WHITEPAPER: Strategic Partnerships with Contract Laboratory Organisations
- WHITEPAPER: Mitigating Risks in Pharmaceutical Batch Release
- WEBINAR: The Fundamentals of Inhaled Product Testing
- WEBINAR: Design Verification Testing (DVT) of Metered DPIs
- ARTICLE: Repurposing Vaccines for Intranasal Development
- Article: Intranasal Delivery of Biologic Therapeutics and Vaccines
- ARTICLE: In Vitro Bioequivalence for Pulmonary and Nasal Delivery
- ARTICLE: Nebulised Drug Development Considerations
- ARTICLE: Overcoming Challenges for Inhaled Biologic Development
- WEBINAR: Repurposing Products for Inhaled Delivery - Rapid Response Strategies
- WEBINAR: Advanced Analytical Techniques for Testing Orally Inhaled and Nasal Drug Products
- WEBINAR: Formulation and Manufacturing Approaches for Nasal Drug Products
- WEBINAR: Formulation Strategies for Orally Inhaled and Nasal Drug Products
- WEBINAR: Stability Programs for Orally Inhaled or Nasal Drug Products
- ARTICLE: Physicochemical Properties of Liposomal Advanced Drug Delivery Technologies
- ARTICLE: Assessing Critical Quality Attributes of Viral Vectors
- BROCHURE: Cell and Gene Therapy Services
- BROCHURE: Biopharmaceutical Services
- BROCHURE: Pharmaceutical Services
- CASE STUDY: Addressing Key Attributes of Viral Vectors
- CASE STUDY: Determining the Proportion of DNA-Packaged and Empty Capsid Populations by Cryo-TEM in Adeno-associated Viruses
- PUBLICATION: Eliminating Residual Impurities Starts with a Strategic Plan
- REPORT: Cell Therapy Analytics and Manufacturing 2019
- VIDEO: GMP CryoTEM Services: Supporting the development of safe and effective advanced therapies
- VIDEO: Cell and Gene Therapy Analytical Development Services
- WEBINAR: Analysis of Delivery Systems for Gene Therapies
- WEBINAR: Comparison of qPCR and ddPCR methods for Residual DNA Analysis
- WEBINAR: Optimising Protein Impurity Analysis for AAV Capsids
- WHITEPAPER: Strategic Partnerships with Contract Laboratory Organisations
- WHITEPAPER: Mitigating Risks in Pharmaceutical Batch Release
- ARTICLE: CMC Considerations for mRNA Based Therapeutics
- ARTICLE: mRNA Analytical Development and CMC Support
- ARTICLE: Physicochemical Properties of Liposomal Advanced Drug Delivery Technologies
- BROCHURE: Biopharmaceutical Services
- BROCHURE: Oligonucleotide Development Support Services
- BROCHURE: Pharmaceutical Services
- CASE STUDY: Determination of Melting Temperature for Oligonucleotide Duplexes using NMR
- CASE STUDY: GMP Batch Release of Oligonucleotides - Identification Testing by Accurate Mass and MS/MS Sequencing
- CASE STUDY: Oligonucleotide Identification, Assay and Impurities
- PUBLICATION: Highlighting Oligonucleotide Characterization Techniques
- REPORT: Analytical Challenges: Characterisation of Oligonucleotide Therapeutics
- WEBINAR: Development of a QC Strategy for Vaccines (Digital TIDES Week 2020)
- WEBINAR: Comparison of qPCR and ddPCR Methods for Residual DNA Analysis
- WEBINAR: CMC Considerations for mRNA-based therapies
- WHITEPAPER: Analytical Strategies for Quality Control of Oligonucleotide Therapeutics
- WHITEPAPER: Strategic Partnerships with Contract Laboratory Organisations
- WHITEPAPER: Mitigating Risks in Pharmaceutical Batch Release
- ARTICLE: Physicochemical Properties of Liposomal Advanced Drug Delivery Technologies
- ARTICLE: Assessing Critical Quality Attributes of Viral Vectors
- BROCHURE: Cell and Gene Therapy Services
- CASE STUDY: Addressing Key Attributes of Viral Vectors
- CASE STUDY: Determining Full Versus Empty Capsids in AAV's with Cryo-TEM
- VIDEO: GMP CryoTEM Services: Supporting the Development of Safe and Effective Advanced Therapies
- WEBINAR: Current Analytical Approached to Advanced Delivery Systems
- WEBINAR: Optimising Protein Impurity Analysis for AAV Capsids
- WHITEPAPER: Strategic Partnerships with Contract Laboratory Organisations
- WHITEPAPER: Mitigating Risks in Pharmaceutical Batch Release
- BROCHURE: Pharmaceutical Services
- FACTSHEET: Nitrosamine Analysis in Medicine
- ARTICLE: The Importance of Aligning a Pharma Audit Scope with the Correct Standard
- ARTICLE: A Strategic Approach for Nitrosamine Impurity Screening in Drug Products
- ARTICLE: Physicochemical Properties of Liposomal Advanced Drug Delivery Technologies
- WEBINAR: Analytical Approaches for Identification and Quantification of Impurities In Pharmaceuticals
- WEBINAR: Characterization and Quantification of Known & Unknown Substances by NMR
- WEBINAR: Extractables and Leachables Studies for Process Materials and Container Closure Systems
- WEBINAR: A Hi-Res Accurate Mass Spectrometry Validated Method for Nitrosamine Analysis
WHITEPAPER: Strategic Partnerships with Contract Laboratory Organisations - WHITEPAPER: Mitigating Risks in Pharmaceutical Batch Release
- Article: Identification and Quantification of Potential Epoxide Genotoxic Impurities
- ARTICLE: Biomarker Development & Validation
- BROCHURE: Bioanalysis Services
- BROCHURE: Biopharmaceutical Services
- BROCHURE Pharmaceutical Services
- FACTSHEET: Trace Metals Bioanalysis and Biomarker Quantification
- FACTSHEET: Biomarker Development and Validation
- WEBINAR: Innovations in Bioanalytical or Immunogenicity Technologies
- WHITEPAPER: Technologies to Measure Immunogenicity
- WHITEPAPER: Bioanalytical Quantitative Determination Of Pegylated Species In Human Plasma By NMR
- WHITEPAPER: Strategic Partnerships with Contract Laboratory Organisations
- WHITEPAPER: Mitigating Risks in Pharmaceutical Batch Release
- WEBINAR: Design of Robust and Sensitive Extractables and Leachables Studies
- WEBINAR: Extractables and Leachables Studies for Process Materials and Container Closure Systems
- WEBINAR: Biocompatibility - The Importance of Extractables & Leachables Testing
- WHITEPAPER: Extractables and Leachables Strategies for Pharmaceutical Production Tubing
- WHITEPAPER: Extractables and Leachables Strategies for Transdermal Delivery Patch Products
- WHITEPAPER: Glass Containers for Pharmaceuticals - Delamination and Interaction Studies
- WHITEPAPER: Trace Analytical Methods and Techniques for Testing Extractables and Leachables
- INFOGRAPHIC: Top 5 Considerations for Outsourcing Stability Storage
- ARTICLE: An Introduction to Inhalation Drug Stability Studies
- BROCHURE: cGMP Stability Study Services
- INFOGRAPHIC: GMP Stability Storage and Testing
- WEBINAR: Outsourcing Stability Studies to Contract Laboratories; Optimising Success
- WEBINAR: Stability Programs for Orally Inhaled or Nasal Drug Products
- WEBINAR: Design of Biopharmaceutical Stability Studies
- WHITEPAPER: Outsourcing Stability Studies to Contract Laboratories - Keys to Success
- WHITEPAPER: Pharmaceutical Stability Contingency Storage and Disaster Recovery
- ARTICLE: Analyzing Leachables from Plastics
- WHITEPAPER: Trace Analysis Methods and Techniques for Testing E&L
- WHITEPAPER: E&L Testing - An Introduction and Strategies in Current Practice
- WHITEPAPER: Elemental Impurities: A Guide to Risk Assessment and Testing
- WHITEPAPER: Outsourcing Stability Studies to Contract Laboratories – Keys to Success
Need help or have a question?
+1 800 967 5352
ASK OUR EXPERT
Have an immediate question? Contact our experts directly with your technical and commercial questions concerning vaccine, therapeutic or diagnostic development support
ASK A QUESTION NOW
Need help or have a question?
COVID-19 VACCINE OR THERAPEUTIC TESTING & DEVELOPMENT SUPPORT
IMMEDIATE QUESTION? Ask our experts now
FACTSHEET: COVID-19 Vaccine or Therapeutic Testing & Development Outsourcing
ARTICLE: Repurposing Vaccines for Intranasal Development
WEBINAR: Quality Control Strategy for Vaccine Development
WEBINAR: Repurposing Drugs for Inhaled Delivery
eBOOK: Contingency Outsourcing Solutions